Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Monument Therapeutics

https://monumenttx.com/

Latest From Monument Therapeutics

UK Biotech Monument Uses Repurposed Drugs To Target CNS Conditions

Emerging Company Profile: Monument Therapeutics’ novel approach to CNS drug development focuses on repurposing existing drugs with the aid of digital biomarkers.   

Neurology Research & Development
See All

Company Information

  • Industry
  • Biotechnology
  • Digital Health
  • Pharmaceuticals
UsernamePublicRestriction

Register